In this insightful discussion, George Scorsis—Executive Chairman of Entourage Health and Board Member at Shuttle Pharmaceuticals—explores how cannabis is transforming the pharmaceutical industry. He highlights the potential of cannabinoid-based drugs, the role of AI and biotechnology, and the future of personalized cannabis medicine in oncology and beyond.
